| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.05 |